| 000 | 00939 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517071009.0 | ||
| 264 | 0 | _c20160725 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a1662-2979 | ||
| 024 | 7 |
_a10.1159/000439323 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKelly, Aaron S | |
| 245 | 0 | 0 |
_aGlucagon-Like Peptide-1 Receptor Agonist Treatment for Pediatric Obesity. _h[electronic resource] |
| 260 |
_bEndocrine development _c2016 |
||
| 300 |
_a23-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIncretins _xadverse effects |
| 650 | 0 | 4 |
_aPediatric Obesity _xdrug therapy |
| 650 | 0 | 4 | _aGlucagon-Like Peptide-1 Receptor Agonists |
| 773 | 0 |
_tEndocrine development _gvol. 30 _gp. 23-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000439323 _zAvailable from publisher's website |
| 999 |
_c25556082 _d25556082 |
||